WINDLAS BIOTECH | SMS LIFESCIENCES INDIA | WINDLAS BIOTECH/ SMS LIFESCIENCES INDIA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 31.7 | 14.6 | 217.8% | View Chart |
P/BV | x | 4.4 | 1.8 | 240.7% | View Chart |
Dividend Yield | % | 0.6 | 0.1 | 399.0% |
WINDLAS BIOTECH SMS LIFESCIENCES INDIA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
WINDLAS BIOTECH Mar-24 |
SMS LIFESCIENCES INDIA Mar-23 |
WINDLAS BIOTECH/ SMS LIFESCIENCES INDIA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 590 | 948 | 62.3% | |
Low | Rs | 226 | 501 | 45.2% | |
Sales per share (Unadj.) | Rs | 303.3 | 903.8 | 33.6% | |
Earnings per share (Unadj.) | Rs | 28.0 | 37.7 | 74.3% | |
Cash flow per share (Unadj.) | Rs | 34.4 | 73.4 | 46.9% | |
Dividends per share (Unadj.) | Rs | 5.50 | 1.50 | 366.7% | |
Avg Dividend yield | % | 1.3 | 0.2 | 650.7% | |
Book value per share (Unadj.) | Rs | 214.0 | 558.3 | 38.3% | |
Shares outstanding (eoy) | m | 20.80 | 3.02 | 688.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.3 | 0.8 | 167.7% | |
Avg P/E ratio | x | 14.6 | 19.2 | 75.8% | |
P/CF ratio (eoy) | x | 11.9 | 9.9 | 120.0% | |
Price / Book Value ratio | x | 1.9 | 1.3 | 146.9% | |
Dividend payout | % | 19.7 | 4.0 | 493.2% | |
Avg Mkt Cap | Rs m | 8,490 | 2,190 | 387.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 875 | 434 | 201.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 6,310 | 2,730 | 231.2% | |
Other income | Rs m | 135 | 31 | 438.4% | |
Total revenues | Rs m | 6,444 | 2,760 | 233.5% | |
Gross profit | Rs m | 782 | 312 | 250.8% | |
Depreciation | Rs m | 134 | 108 | 124.6% | |
Interest | Rs m | 11 | 69 | 16.1% | |
Profit before tax | Rs m | 771 | 166 | 464.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 189 | 52 | 362.4% | |
Profit after tax | Rs m | 582 | 114 | 511.4% | |
Gross profit margin | % | 12.4 | 11.4 | 108.5% | |
Effective tax rate | % | 24.5 | 31.4 | 78.0% | |
Net profit margin | % | 9.2 | 4.2 | 221.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 4,313 | 1,626 | 265.2% | |
Current liabilities | Rs m | 1,718 | 1,371 | 125.3% | |
Net working cap to sales | % | 41.1 | 9.4 | 439.4% | |
Current ratio | x | 2.5 | 1.2 | 211.7% | |
Inventory Days | Days | 106 | 9 | 1,206.5% | |
Debtors Days | Days | 79 | 616 | 12.8% | |
Net fixed assets | Rs m | 1,943 | 2,358 | 82.4% | |
Share capital | Rs m | 104 | 30 | 344.0% | |
"Free" reserves | Rs m | 4,346 | 1,656 | 262.5% | |
Net worth | Rs m | 4,450 | 1,686 | 263.9% | |
Long term debt | Rs m | 0 | 549 | 0.0% | |
Total assets | Rs m | 6,256 | 3,984 | 157.0% | |
Interest coverage | x | 70.8 | 3.4 | 2,071.2% | |
Debt to equity ratio | x | 0 | 0.3 | 0.0% | |
Sales to assets ratio | x | 1.0 | 0.7 | 147.2% | |
Return on assets | % | 9.5 | 4.6 | 207.0% | |
Return on equity | % | 13.1 | 6.7 | 193.8% | |
Return on capital | % | 17.6 | 10.5 | 167.4% | |
Exports to sales | % | 0 | 36.5 | 0.0% | |
Imports to sales | % | 0 | 26.4 | 0.0% | |
Exports (fob) | Rs m | NA | 998 | 0.0% | |
Imports (cif) | Rs m | NA | 720 | 0.0% | |
Fx inflow | Rs m | 313 | 998 | 31.4% | |
Fx outflow | Rs m | 75 | 724 | 10.4% | |
Net fx | Rs m | 238 | 273 | 87.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,090 | 147 | 741.5% | |
From Investments | Rs m | -921 | -313 | 294.2% | |
From Financial Activity | Rs m | -153 | 169 | -90.5% | |
Net Cashflow | Rs m | 16 | 3 | 548.6% |
Indian Promoters | % | 62.5 | 71.4 | 87.5% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 11.6 | 0.0 | 57,900.0% | |
FIIs | % | 2.0 | 0.0 | 10,000.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 37.5 | 28.6 | 131.1% | |
Shareholders | 45,706 | 7,849 | 582.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare WINDLAS BIOTECH With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | WINDLAS BIOTECH | SMS LIFESCIENCES INDIA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.44% | -1.76% | 0.61% |
1-Month | -2.08% | -29.77% | -0.86% |
1-Year | 110.59% | 100.03% | 42.74% |
3-Year CAGR | 49.01% | 7.24% | 20.10% |
5-Year CAGR | 17.98% | 28.77% | 26.09% |
* Compound Annual Growth Rate
Here are more details on the WINDLAS BIOTECH share price and the SMS LIFESCIENCES INDIA share price.
Moving on to shareholding structures...
The promoters of WINDLAS BIOTECH hold a 62.5% stake in the company. In case of SMS LIFESCIENCES INDIA the stake stands at 71.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of WINDLAS BIOTECH and the shareholding pattern of SMS LIFESCIENCES INDIA.
Finally, a word on dividends...
In the most recent financial year, WINDLAS BIOTECH paid a dividend of Rs 5.5 per share. This amounted to a Dividend Payout ratio of 19.7%.
SMS LIFESCIENCES INDIA paid Rs 1.5, and its dividend payout ratio stood at 4.0%.
You may visit here to review the dividend history of WINDLAS BIOTECH, and the dividend history of SMS LIFESCIENCES INDIA.
For a sector overview, read our pharmaceuticals sector report.
Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.